These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

157 related articles for article (PubMed ID: 10090080)

  • 1. A ret transgenic mouse model of thyroid carcinogenesis.
    Capen C; Sagartz J
    Lab Anim Sci; 1998 Dec; 48(6):580-3. PubMed ID: 10090080
    [No Abstract]   [Full Text] [Related]  

  • 2. Targeted expression of the ret/PTC1 oncogene induces papillary thyroid carcinomas.
    Jhiang SM; Sagartz JE; Tong Q; Parker-Thornburg J; Capen CC; Cho JY; Xing S; Ledent C
    Endocrinology; 1996 Jan; 137(1):375-8. PubMed ID: 8536638
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Thyroid carcinomas in RET/PTC transgenic mice.
    Jhiang SM; Cho JY; Furminger TL; Sagartz JE; Tong Q; Capen CC; Mazzaferri EL
    Recent Results Cancer Res; 1998; 154():265-70. PubMed ID: 10027006
    [TBL] [Abstract][Full Text] [Related]  

  • 4. RET/PTC oncogene activation is an early event in thyroid carcinogenesis.
    Viglietto G; Chiappetta G; Martinez-Tello FJ; Fukunaga FH; Tallini G; Rigopoulou D; Visconti R; Mastro A; Santoro M; Fusco A
    Oncogene; 1995 Sep; 11(6):1207-10. PubMed ID: 7566982
    [TBL] [Abstract][Full Text] [Related]  

  • 5. The RET/PTC3 oncogene: metastatic solid-type papillary carcinomas in murine thyroids.
    Powell DJ; Russell J; Nibu K; Li G; Rhee E; Liao M; Goldstein M; Keane WM; Santoro M; Fusco A; Rothstein JL
    Cancer Res; 1998 Dec; 58(23):5523-8. PubMed ID: 9850089
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Development of thyroid papillary carcinomas secondary to tissue-specific expression of the RET/PTC1 oncogene in transgenic mice.
    Santoro M; Chiappetta G; Cerrato A; Salvatore D; Zhang L; Manzo G; Picone A; Portella G; Santelli G; Vecchio G; Fusco A
    Oncogene; 1996 Apr; 12(8):1821-6. PubMed ID: 8622903
    [TBL] [Abstract][Full Text] [Related]  

  • 7. The ret/PTC oncogene in papillary thyroid carcinoma.
    Jhiang SM; Mazzaferri EL
    J Lab Clin Med; 1994 Mar; 123(3):331-7. PubMed ID: 8133143
    [No Abstract]   [Full Text] [Related]  

  • 8. [The RET gene in thyroid pathology].
    Michiels FM; Billaud M
    Arch Anat Cytol Pathol; 1998; 46(1-2):19-30. PubMed ID: 9754357
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Familial papillary carcinoma of the thyroid.
    Kraimps JL; Bouin-Pineau MH; Amati P; Mothes D; Bonneau D; Maréchaud R; Barbier J
    Surgery; 1997 Jun; 121(6):715-8. PubMed ID: 9186475
    [No Abstract]   [Full Text] [Related]  

  • 10. Molecular characterization of RET/PTC3; a novel rearranged version of the RETproto-oncogene in a human thyroid papillary carcinoma.
    Santoro M; Dathan NA; Berlingieri MT; Bongarzone I; Paulin C; Grieco M; Pierotti MA; Vecchio G; Fusco A
    Oncogene; 1994 Feb; 9(2):509-16. PubMed ID: 8290261
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Prevalence, significance, and biological behavior of ret/PTC1 associated papillary thyroid carcinoma.
    Cetta F
    J Clin Endocrinol Metab; 1997 May; 82(5):1650. PubMed ID: 9141569
    [No Abstract]   [Full Text] [Related]  

  • 12. RET/PTC oncogene activation defines a subset of papillary thyroid carcinomas lacking evidence of progression to poorly differentiated or undifferentiated tumor phenotypes.
    Tallini G; Santoro M; Helie M; Carlomagno F; Salvatore G; Chiappetta G; Carcangiu ML; Fusco A
    Clin Cancer Res; 1998 Feb; 4(2):287-94. PubMed ID: 9516913
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Rearrangements of RET and NTRK1 tyrosine kinase receptors in papillary thyroid carcinomas.
    Pierotti MA; Vigneri P; Bongarzone I
    Recent Results Cancer Res; 1998; 154():237-47. PubMed ID: 10027004
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Different significance of ret/PTC(1) and ret/PTC(3) rearrangements in thyroid carcinogenesis: lesson from two subgroups of patients with papillary thyroid carcinomas showing the highest incidence of ret/PTC activation.
    Cetta F; Gori M; Montalto G; Zuckermann M; Toti P
    J Clin Endocrinol Metab; 2001 Mar; 86(3):1429. PubMed ID: 11238550
    [No Abstract]   [Full Text] [Related]  

  • 15. Correspondence re: G. Tallini et al., RET/PTC oncogene activation defines a subset of papillary thyroid carcinomas lacking evidence of progression to poorly differentiated or undifferentiated tumor phenotype. Clin. Cancer Res., 4:287-294, 1998.
    Soares P; Sobrinho-Simões M
    Clin Cancer Res; 1999 Nov; 5(11):3724-5. PubMed ID: 10589793
    [No Abstract]   [Full Text] [Related]  

  • 16. Thyroid carcinoma: diagnostic and therapeutic approach; genetic background (review).
    Lewinski A; Ferenc T; Sporny S; Jarzab B
    Endocr Regul; 2000 Jun; 34(2):99-113. PubMed ID: 10991553
    [No Abstract]   [Full Text] [Related]  

  • 17. Low frequency of rearrangements of the ret and trk proto-oncogenes in Japanese thyroid papillary carcinomas.
    Wajjwalku W; Nakamura S; Hasegawa Y; Miyazaki K; Satoh Y; Funahashi H; Matsuyama M; Takahashi M
    Jpn J Cancer Res; 1992 Jul; 83(7):671-5. PubMed ID: 1381340
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Multiple endocrine neoplasia type 2B mutation in human RET oncogene induces medullary thyroid carcinoma in transgenic mice.
    Acton DS; Velthuyzen D; Lips CJ; Höppener JW
    Oncogene; 2000 Jun; 19(27):3121-5. PubMed ID: 10871866
    [TBL] [Abstract][Full Text] [Related]  

  • 19. RET oncogene puzzle in Chernobyl thyroid tumours.
    Bonn D
    Lancet; 1996 Apr; 347(9009):1176. PubMed ID: 8609764
    [No Abstract]   [Full Text] [Related]  

  • 20. C-cell and thyroid epithelial tumours and altered follicular development in transgenic mice expressing the long isoform of MEN 2A RET.
    Reynolds L; Jones K; Winton DJ; Cranston A; Houghton C; Howard L; Ponder BA; Smith DP
    Oncogene; 2001 Jul; 20(30):3986-94. PubMed ID: 11494127
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.